A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 506 participants.
Also called NCT01462877
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 506 participants
- Sponsor
- Registry
-
NCT01462877
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01462877. Allocation not applicable; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-02 (actual). Results posted on 2015-02-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic
- Condition
- Dyslipidemias
- Condition
- Cardiovascular Diseases
- Condition
- Hypertriglyceridemia
- Intervention (Drug)
- fenofibrate
- Lead sponsor
- Abbott
- Collaborator
- Rundo International Pharmaceutical Research & Development Co.,Ltd.
Record details
- Record id
cardio:ct-nct01462877- Content hash
1fd022dda2f8092ea4d01951a5d937a94b123ab5e3431c94b98f6bbe0b03323d